Marion Laboratories and the Ewing Marion Kauffman Foundation

Marion Laboratories and the Ewing Marion Kauffman Foundation trace one of Kansas City’s defining business-and-philanthropy stories. Ewing Marion Kauffman founded Marion Laboratories in his basement in 1950 with $5,000 and grew it into a billion-dollar pharmaceutical company. Its 1989 merger with Merrell Dow created Marion Merrell Dow and minted hundreds of local “Marion millionaires.” Kauffman also brought Major League Baseball back to the city as the founding owner of the Kansas City Royals, and he endowed the Ewing Marion Kauffman Foundation, today among the largest U.S. foundations devoted to entrepreneurship.

Ewing Kauffman and the founding of Marion Labs

Ewing Marion Kauffman (1916–1993) was a Kansas City pharmaceutical salesman before he became a company founder. He earned a reputation as a top performer on commission — well enough, by most accounts, that the disparity between his earnings and his employer’s expectations pushed him toward striking out on his own.¹

In 1950 Kauffman started Marion Laboratories in the basement of his Kansas City home, capitalizing it with $5,000 (often described as poker winnings from his Navy service).¹² The company’s first product line centered on pharmaceutical calcium supplements sold to physicians and pharmacists. In its first year Marion recorded roughly $36,000 in gross sales and about $1,000 in profit.² The name “Marion” came from Kauffman’s own middle name, drawn from his mother’s family — a deliberate choice so customers would not assume the founder was peddling products under his own surname.¹

Kauffman built Marion around an unusual employee philosophy. Workers were called “associates,” and the company offered profit-sharing, stock options, and education benefits that were uncommon in mid-century industry. The approach created real wealth for ordinary employees: by 1968, around twenty Marion associates had become millionaires, including a widow in the accounting department.²³

Growth and the Merrell Dow merger

Marion Laboratories grew steadily through the 1950s and 1960s, broadening its product line through both in-house development and licensing, and going public on the New York Stock Exchange in 1965.¹

The company’s signature product was Cardizem (diltiazem), a calcium-channel-blocker cardiovascular drug that Marion licensed from the Japanese firm Tanabe Seiyaku and brought to the U.S. market in the early 1980s.⁴ Cardizem became one of the best-selling cardiovascular drugs in the country and pushed Marion toward Fortune 500 scale. A second Tanabe-derived product, Carafate (sucralfate) for ulcer treatment, added to the franchise.⁴

In 1989, with annual sales topping $1 billion, Marion merged with Merrell Dow Pharmaceuticals (a Dow Chemical subsidiary) to form Marion Merrell Dow, Inc., then one of the largest U.S. pharmaceutical companies.⁴⁵ The merger turned hundreds of Kansas City employees into millionaires — the local cohort long remembered as “Marion millionaires.”² Kauffman served as chairman emeritus of the combined company until his death.¹

After Kauffman’s death, Marion Merrell Dow passed through a sequence of corporate owners: acquired by Germany’s Hoechst AG in 1995 (becoming Hoechst Marion Roussel), folded into Aventis in 1999, and into Sanofi in 2004.⁴ Elements of the original Kansas City operation persisted through these transitions, though at reduced scale from the Marion peak.

Ewing Marion Kauffman died on August 1, 1993, in Kansas City at age 76.¹

The Kansas City Royals

In 1968, Major League Baseball awarded Kauffman an expansion franchise to return big-league baseball to Kansas City after the Athletics left for Oakland. The team — named the Royals in honor of the American Royal livestock show, a civic fixture since 1899 — began play in 1969 at Municipal Stadium and moved to the new Royals Stadium at the Truman Sports Complex in 1973.³⁶

Under Kauffman’s ownership the Royals became a consistent contender, reaching the postseason repeatedly in the late 1970s and 1980s and winning the 1985 World Series over the St. Louis Cardinals.⁶ Kauffman owned the club for the rest of his life. To guard against relocation, he structured an arrangement transferring the franchise to a community foundation after his death; the team was later sold to David Glass (2000) and to John Sherman (2019), and won a second title in the 2015 World Series.⁶

Royals Stadium was renamed Kauffman Stadium after his 1993 death. Part of the Truman Sports Complex alongside Arrowhead Stadium, the ballpark is known for its outfield fountains (kauffman-stadium-fountains) and crown-shaped scoreboard, and it remains a fixture of the city’s sports identity.⁶

The Kauffman Foundation

Kauffman established the Ewing Marion Kauffman Foundation in 1966, funding it over time with Marion Laboratories stock and, after the merger, Marion Merrell Dow shares; his estate enlarged the endowment after his death.⁷ Headquartered at 4801 Rockhill Road near the Country Club Plaza, it is today among the largest U.S. private foundations, with an endowment commonly reported at roughly $2.7 billion.⁷

The Foundation concentrates on three areas: advancing entrepreneurship, improving education, and supporting civic development in Kansas City.⁷ It is widely regarded as the most influential American foundation focused specifically on entrepreneurship, producing research and policy work cited at federal, state, and local levels. Locally, its grants have supported UMKC and other educational institutions, the Kauffman Scholars program for students from underserved backgrounds, and major civic projects.

Legacy

Marion Laboratories was the most important pharmaceutical company in Kansas City history, anchoring local research, manufacturing, and corporate employment at its peak. Through the Royals, Kauffman returned and rooted Major League Baseball in the city; through the Foundation, he created a national center of gravity for entrepreneurship research while channeling decades of investment into Kansas City’s schools and civic life.

Taken together, the Kauffman legacy belongs to a distinctive Kansas City tradition of family-built companies turned civic philanthropy — alongside the Hall family (Hallmark), the Bloch family (H&R Block), and the Kemper family (Commerce Bank) — that has shaped the city’s cultural and educational institutions across multiple generations.

Sources

Footnotes

1. Anne Morgan, Prescription for Success: The Life and Values of Ewing Marion Kauffman (biography); Philanthropy Roundtable, “Ewing Kauffman” Hall of Fame profile. https://www.philanthropyroundtable.org/hall-of-fame/ewing-kauffman/ ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶

2. Philanthropy Roundtable, “Ewing Kauffman” — founding in 1950 with $5,000, first-year sales of ~$36,000, employee profit-sharing and the rise of “Marion millionaires.” ↩ ↩² ↩³ ↩⁴

3. Ewing Marion Kauffman Foundation, “The Legacy of Ewing Marion Kauffman / The Kauffman Years (1968–1993).” https://www.kauffman.org/emk/kauffman/ ↩ ↩²

4. Marion Merrell Dow, Inc., corporate history (Encyclopedia.com; FundingUniverse) — Cardizem and Carafate licensed from Tanabe Seiyaku; 1989 merger; later Hoechst/Aventis/Sanofi ownership. https://www.encyclopedia.com/books/politics-and-business-magazines/marion-merrell-dow-inc ↩ ↩² ↩³ ↩⁴

5. UPI Archives, “Marion Labs, Dow Chemical announce agreement,” July 17, 1989. https://www.upi.com/Archives/1989/07/17/Marion-Labs-Dow-Chemical-announce-agreement/3454616651200/ ↩

6. Ewing Marion Kauffman Foundation, “5 ways Ewing Kauffman changed baseball”; Kansas City Royals franchise history; Kansas City Star coverage of the 1985 and 2015 World Series. https://www.kauffman.org/currents/5-ways-ewing-marion-kauffman-changed-baseball/ ↩ ↩² ↩³ ↩⁴

7. Ewing Marion Kauffman Foundation, institutional materials and Wikipedia summary — founded 1966; endowment ~$2.7 billion; focus on entrepreneurship, education, and Kansas City civic development. https://en.wikipedia.org/wiki/Ewing_Marion_Kauffman_Foundation ↩ ↩² ↩³